强直性-话题@MedSci

#强直性#

138篇内容 | 3116人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1946925, encodeId=c0f119469256f, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=强直性脊柱炎典型影像表现及其病理生理, objectType=article, longId=295267, objectId=0bdd29526e30, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bdd29526e30, replyNumber=0, likeNumber=88, createdTime=2022-11-16, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bdd29526e30, moduleTitle=强直性脊柱炎典型影像表现及其病理生理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bdd29526e30)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946916, encodeId=37711946916d6, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=Ann Rheum Dis：托法替尼治疗强直性脊柱炎的III期试验结果, objectType=article, longId=214492, objectId=c20e21449280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c20e21449280, replyNumber=0, likeNumber=85, createdTime=2021-12-15, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c20e21449280, moduleTitle=Ann Rheum Dis：托法替尼治疗强直性脊柱炎的III期试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c20e21449280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946906, encodeId=2a19194690676, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=治疗类风湿关节炎和强直性脊柱炎的生物制剂进入国家医保目录, objectType=article, longId=208008, objectId=22a520800864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22a520800864, replyNumber=0, likeNumber=71, createdTime=2022-02-19, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22a520800864, moduleTitle=治疗类风湿关节炎和强直性脊柱炎的生物制剂进入国家医保目录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22a520800864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946921, encodeId=10d5194692148, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=Rheumatology ：非戈替尼对活动期强直性脊柱炎患者12周骶髂关节磁共振成像结构损害的影响(Tortuga试验), objectType=article, longId=219183, objectId=2ebe21918366, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ebe21918366, replyNumber=0, likeNumber=77, createdTime=2022-09-08, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ebe21918366, moduleTitle=Rheumatology ：非戈替尼对活动期强直性脊柱炎患者12周骶髂关节磁共振成像结构损害的影响(Tortuga试验), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ebe21918366)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946908, encodeId=76a2194690884, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=Arthritis Res Ther：IL-17抑制剂治疗强直性脊柱炎的疗效和安全性如何？, objectType=article, longId=210764, objectId=061a210e6467, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=061a210e6467, replyNumber=0, likeNumber=76, createdTime=2021-05-21, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=061a210e6467, moduleTitle=Arthritis Res Ther：IL-17抑制剂治疗强直性脊柱炎的疗效和安全性如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=061a210e6467)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946913, encodeId=3e12194691369, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=Int J Rheum Dis：长期随访结果表明手术仍然是强直性脊柱炎患者AL的更佳治疗方法, objectType=article, longId=210809, objectId=cf64210809c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf64210809c9, replyNumber=0, likeNumber=84, createdTime=2021-08-11, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf64210809c9, moduleTitle=Int J Rheum Dis：长期随访结果表明手术仍然是强直性脊柱炎患者AL的更佳治疗方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf64210809c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946920, encodeId=7a6919469209b, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=Rheumatology：强直性脊柱炎患者淀粉样变性的风险、预测因素和预后, objectType=article, longId=219095, objectId=2d48219095d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d48219095d4, replyNumber=0, likeNumber=94, createdTime=2022-05-05, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d48219095d4, moduleTitle=Rheumatology：强直性脊柱炎患者淀粉样变性的风险、预测因素和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d48219095d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946909, encodeId=34c1194690977, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=Clin Exp Rheumatol：2期临床试验结果证实尼塔奇单抗对活动性强直性脊柱炎良好的疗效和安全性, objectType=article, longId=210766, objectId=f03d210e6684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f03d210e6684, replyNumber=0, likeNumber=112, createdTime=2021-08-18, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f03d210e6684, moduleTitle=Clin Exp Rheumatol：2期临床试验结果证实尼塔奇单抗对活动性强直性脊柱炎良好的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f03d210e6684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946918, encodeId=c91019469188e, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=J Rheumatol：银屑病关节炎、银屑病、类风湿性关节炎和强直性脊柱炎的危险因素, objectType=article, longId=216562, objectId=4c5b21656221, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c5b21656221, replyNumber=0, likeNumber=76, createdTime=2022-06-17, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c5b21656221, moduleTitle=J Rheumatol：银屑病关节炎、银屑病、类风湿性关节炎和强直性脊柱炎的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c5b21656221)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946917, encodeId=dfbd194691e49, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=Ann Rheum Dis：多基因风险评分对强直性脊柱炎具有很高的诊断价值, objectType=article, longId=216305, objectId=f108216305bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f108216305bb, replyNumber=0, likeNumber=81, createdTime=2022-05-22, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f108216305bb, moduleTitle=Ann Rheum Dis：多基因风险评分对强直性脊柱炎具有很高的诊断价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f108216305bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946910, encodeId=5d0b194691095, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=Disabil Rehabil：水疗法可以减少强直性脊柱炎的疾病活动性并减轻疼痛, objectType=article, longId=210770, objectId=b498210e708e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b498210e708e, replyNumber=0, likeNumber=79, createdTime=2021-08-25, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b498210e708e, moduleTitle=Disabil Rehabil：水疗法可以减少强直性脊柱炎的疾病活动性并减轻疼痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b498210e708e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946912, encodeId=408d1946912d4, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=PLoS One：强直性脊柱炎患者的治疗现状选择, objectType=article, longId=210803, objectId=7b87210803f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b87210803f8, replyNumber=0, likeNumber=75, createdTime=2021-05-05, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b87210803f8, moduleTitle=PLoS One：强直性脊柱炎患者的治疗现状选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b87210803f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946911, encodeId=1465194691153, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=BioDrugs：生物制剂在治疗强直性脊柱炎中的药物用药率如何？, objectType=article, longId=210771, objectId=1bf4210e71a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bf4210e71a3, replyNumber=0, likeNumber=0, createdTime=2021-09-26, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bf4210e71a3, moduleTitle=BioDrugs：生物制剂在治疗强直性脊柱炎中的药物用药率如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bf4210e71a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946915, encodeId=192f1946915bf, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=Arthritis Res Ther：英夫利昔单抗通过改善疾病症状来改善强直性脊柱炎患者的抑郁症状, objectType=article, longId=210813, objectId=c69b210813b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c69b210813b3, replyNumber=0, likeNumber=92, createdTime=2021-06-21, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c69b210813b3, moduleTitle=Arthritis Res Ther：英夫利昔单抗通过改善疾病症状来改善强直性脊柱炎患者的抑郁症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c69b210813b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946904, encodeId=58e6194690475, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=XELJANZ（tofacitinib）治疗强直性脊柱炎（AS）：III期研究取得阳性结果, objectType=article, longId=203133, objectId=529b20313392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=529b20313392, replyNumber=0, likeNumber=71, createdTime=2021-10-03, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=529b20313392, moduleTitle=XELJANZ（tofacitinib）治疗强直性脊柱炎（AS）：III期研究取得阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=529b20313392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946905, encodeId=f2381946905c4, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=恒瑞 IL-17A单抗SHR-1314用于强直性脊柱炎获批临床试验, objectType=article, longId=203507, objectId=ccd220350e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccd220350e2c, replyNumber=0, likeNumber=69, createdTime=2020-11-25, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccd220350e2c, moduleTitle=恒瑞 IL-17A单抗SHR-1314用于强直性脊柱炎获批临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccd220350e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946901, encodeId=e941194690119, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=J Rheumatol：强直性脊柱炎患者的听力丧失, objectType=article, longId=194298, objectId=4022194298ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4022194298ff, replyNumber=0, likeNumber=104, createdTime=2020-11-06, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4022194298ff, moduleTitle=J Rheumatol：强直性脊柱炎患者的听力丧失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4022194298ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946899, encodeId=84741946899da, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=Ann Rheum Dis：bimekizumab双重中和白介素-17A和17F治疗活动性强直性脊柱炎, objectType=article, longId=191751, objectId=d3f2191e51d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3f2191e51d1, replyNumber=0, likeNumber=64, createdTime=2020-09-16, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3f2191e51d1, moduleTitle=Ann Rheum Dis：bimekizumab双重中和白介素-17A和17F治疗活动性强直性脊柱炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3f2191e51d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946897, encodeId=0beb194689e34, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=J Rheumatol：强直性脊柱炎患者椎体骨折的风险和后果, objectType=article, longId=189080, objectId=7a86189080e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a86189080e1, replyNumber=0, likeNumber=66, createdTime=2020-09-19, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a86189080e1, moduleTitle=J Rheumatol：强直性脊柱炎患者椎体骨折的风险和后果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a86189080e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946903, encodeId=89fa1946903de, content=<a href='/topic/show?id=9a3950183e9' target=_blank style='color:#2F92EE;'>#强直性#</a>, objectTitle=Ann Rheum Dis：肿瘤坏死因子抑制剂可减慢强直性脊柱炎的影像学进展, objectType=article, longId=197868, objectId=fc7a19e8685e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc7a19e8685e, replyNumber=0, likeNumber=82, createdTime=2021-01-25, rootId=0, userName=zywlvao, userId=bc9a2500116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc7a19e8685e, moduleTitle=Ann Rheum Dis：肿瘤坏死因子抑制剂可减慢强直性脊柱炎的影像学进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc7a19e8685e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

强直性

2020-05-29

zywlvao (审核中...)

前往app查看评论内容

#强直性#

强直性脊柱炎典型影像表现及其病理生理

2022-11-16

zywlvao (审核中...)

前往app查看评论内容

#强直性#

Ann Rheum Dis：托法替尼治疗强直性脊柱炎的III期试验结果

2021-12-15

zywlvao (审核中...)

前往app查看评论内容

#强直性#

治疗类风湿关节炎和强直性脊柱炎的生物制剂进入国家医保目录

2022-02-19

zywlvao (审核中...)

前往app查看评论内容

#强直性#

Rheumatology ：非戈替尼对活动期强直性脊柱炎患者12周骶髂关节磁共振成像结构损害的影响(Tortuga试验)

2022-09-08

zywlvao (审核中...)

前往app查看评论内容

#强直性#

Arthritis Res Ther：IL-17抑制剂治疗强直性脊柱炎的疗效和安全性如何？

2021-05-21

zywlvao (审核中...)

前往app查看评论内容

#强直性#

Int J Rheum Dis：长期随访结果表明手术仍然是强直性脊柱炎患者AL的更佳治疗方法

2021-08-11

zywlvao (审核中...)

前往app查看评论内容

#强直性#

Rheumatology：强直性脊柱炎患者淀粉样变性的风险、预测因素和预后

2022-05-05

zywlvao (审核中...)

前往app查看评论内容

#强直性#

Clin Exp Rheumatol：2期临床试验结果证实尼塔奇单抗对活动性强直性脊柱炎良好的疗效和安全性

2021-08-18

zywlvao (审核中...)

前往app查看评论内容

#强直性#

J Rheumatol：银屑病关节炎、银屑病、类风湿性关节炎和强直性脊柱炎的危险因素

2022-06-17

zywlvao (审核中...)

前往app查看评论内容

#强直性#

Ann Rheum Dis：多基因风险评分对强直性脊柱炎具有很高的诊断价值

2022-05-22

zywlvao (审核中...)

前往app查看评论内容

#强直性#

Disabil Rehabil：水疗法可以减少强直性脊柱炎的疾病活动性并减轻疼痛

2021-08-25

zywlvao (审核中...)

前往app查看评论内容

#强直性#

PLoS One：强直性脊柱炎患者的治疗现状选择

2021-05-05

zywlvao (审核中...)

前往app查看评论内容

#强直性#

BioDrugs：生物制剂在治疗强直性脊柱炎中的药物用药率如何？

2021-09-26

zywlvao (审核中...)

前往app查看评论内容

#强直性#

Arthritis Res Ther：英夫利昔单抗通过改善疾病症状来改善强直性脊柱炎患者的抑郁症状

2021-06-21

zywlvao (审核中...)

前往app查看评论内容

#强直性#

XELJANZ（tofacitinib）治疗强直性脊柱炎（AS）：III期研究取得阳性结果

2021-10-03

zywlvao (审核中...)

前往app查看评论内容

#强直性#

恒瑞 IL-17A单抗SHR-1314用于强直性脊柱炎获批临床试验

2020-11-25

zywlvao (审核中...)

前往app查看评论内容

#强直性#

J Rheumatol：强直性脊柱炎患者的听力丧失

2020-11-06

zywlvao (审核中...)

前往app查看评论内容

#强直性#

Ann Rheum Dis：bimekizumab双重中和白介素-17A和17F治疗活动性强直性脊柱炎

2020-09-16

zywlvao (审核中...)

前往app查看评论内容

#强直性#

J Rheumatol：强直性脊柱炎患者椎体骨折的风险和后果

2020-09-19

zywlvao (审核中...)

前往app查看评论内容

#强直性#

Ann Rheum Dis：肿瘤坏死因子抑制剂可减慢强直性脊柱炎的影像学进展

2021-01-25

科室
- - 订阅+
  - 更多科室
工具
服务